4.7 Article

A novel microRNA signature for the detection of melanoma by liquid biopsy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Circular RNA circDVL1 inhibits clear cell renal cell carcinoma progression through the miR-412-3p/PCDH7

Ying Wang et al.

Summary: This study found that circDVL1 is reduced in the serums and tissues from ccRCC patients, and negatively correlates with malignant features of ccRCC. Overexpression of circDVL1 inhibits proliferation and migration, induces apoptosis in ccRCC cells. Mechanistically, circDVL1 functions as a sponge for miR-412-3p, preventing its repression of target gene PCDH7 in ccRCC cells.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)

Review Cell Biology

microRNA-based diagnostic and therapeutic applications in cancer medicine

Lorenzo F. Sempere et al.

Summary: The link between microRNAs and cancer has been established for almost two decades, with extensive research applied to various cancer types. These studies have led to significant advances in microRNA detection technology, biomarker development, and gene expression regulatory mechanisms, but translating these findings into clinical tools still faces challenges.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)

Article Oncology

5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAF(V600) Mutation-Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Paolo A. Ascierto et al.

Summary: The long-term follow-up of the coBRIM study confirmed the extended clinical benefit and safety profile of cobimetinib plus vemurafenib compared to vemurafenib monotherapy in patients with BRAF(V600) mutation-positive advanced melanoma. The study showed improved progression-free survival and overall survival in the cobimetinib plus vemurafenib group, with the safety profile remaining consistent with previous reports.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases

Anna Maria Di Giacomo et al.

Summary: The study compared the efficacy of ipilimumab plus nivolumab with fotemustine in treating melanoma patients with brain metastases, showing that ipilimumab plus nivolumab significantly improved overall and long-term survival rates for patients.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma

Rossella Puglisi et al.

Summary: Cutaneous Melanoma is a form of skin cancer characterized by elevated mutational load, high spread to distant organs, and resistance to therapies. Identification of biomarkers is crucial for accurate description of melanoma, early diagnosis, and selecting the best therapeutic option. New biomarkers are being evaluated for clinical use, but validation is still needed before their application. Regular updates on advances in this field are crucial for progress in melanoma research and treatment.

CANCERS (2021)

Article Multidisciplinary Sciences

Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells

Priyanka Sharma et al.

SCIENTIFIC REPORTS (2020)

Article Cell Biology

Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis

Jingjing Li et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Immunology

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

Maria A. S. Broggi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Article Medicine, Research & Experimental

MiR-362-3p is downregulated by promoter methylation and independently predicts shorter OS of cervical squamous cell carcinoma

Lili Song et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Medicine, General & Internal

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

C. Robert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Oncology

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial

Anna Maria Di Giacomo et al.

CLINICAL CANCER RESEARCH (2019)

Article Medicine, General & Internal

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

J. Larkin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Cell Biology

Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease

Marcelo A. Mori et al.

CELL METABOLISM (2019)

Article Biochemistry & Molecular Biology

MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma

Dan Wang et al.

BIOSCIENCE REPORTS (2018)

Article Oncology

Serum exosomal microRNAs as potent circulating biomarkers for melanoma

Li Tengda et al.

MELANOMA RESEARCH (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Cell Biology

Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma

Priyanka Sharma et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Article Biotechnology & Applied Microbiology

An integrated expression atlas of miRNAs and their promoters in human and mouse

Derek de Rie et al.

NATURE BIOTECHNOLOGY (2017)

Article Multidisciplinary Sciences

Comparison of miRNA quantitation by Nanostring in serum and plasma samples

Catherine Foye et al.

PLOS ONE (2017)

Article Biochemistry & Molecular Biology

Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer

H. Kang et al.

CELL DEATH AND DIFFERENTIATION (2016)

Review Medicine, Research & Experimental

Extracellular vesicles: masters of intercellular communication and potential clinical interventions

Jonathan M. Pitt et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Multidisciplinary Sciences

Plasma extracellular RNA profiles in healthy and cancer patients

Tiezheng Yuan et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

The role of MicroRNAs in human cancer

Yong Peng et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)

Article Medicine, General & Internal

Detection of Exosomal miRNAs in the Plasma of Melanoma Patients

Susan R. Pfeffer et al.

JOURNAL OF CLINICAL MEDICINE (2015)

Article Medical Laboratory Technology

Study of Circulating MicroRNA-125b Levels in Serum Exosomes in Advanced Melanoma

Estibaliz Alegre et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)

Article Instruments & Instrumentation

Profiling of circulating microRNAs for prostate cancer biomarker discovery

Christa Haldrup et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)

Article Genetics & Heredity

The Impact of Hemolysis on Cell-Free microRNA Biomarkers

Michaela B. Kirschner et al.

Frontiers in Genetics (2013)

Review Medicine, Research & Experimental

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

Marilena V. Iorio et al.

EMBO MOLECULAR MEDICINE (2012)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Article Biochemical Research Methods

pROC: an open-source package for R and S plus to analyze and compare ROC curves

Xavier Robin et al.

BMC BIOINFORMATICS (2011)

Article Computer Science, Interdisciplinary Applications

Regularization Paths for Generalized Linear Models via Coordinate Descent

Jerome Friedman et al.

JOURNAL OF STATISTICAL SOFTWARE (2010)

Article Biochemical Research Methods

HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R

Heidi Dvinge et al.

BIOINFORMATICS (2009)

Article Biotechnology & Applied Microbiology

MicroRNAs accurately identify cancer tissue origin

Nitzan Rosenfeld et al.

NATURE BIOTECHNOLOGY (2008)

Article Multidisciplinary Sciences

Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

GA Calin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)